3 Undervalued Small Caps With Insider Action Across Regions

Nutex Health Inc

Nutex Health Inc

NUTX

0.00

The United States market has shown a robust performance, climbing 1.6% in the last week and an impressive 28% over the past year, with earnings projected to grow by 17% annually. In this dynamic environment, identifying stocks that are potentially undervalued can be crucial for investors looking to capitalize on growth opportunities, especially when there is notable insider action signaling confidence in these companies' prospects.

Top 10 Undervalued Small Caps With Insider Buying In The United States

Name PE PS Discount to Fair Value Value Rating
Financial Institutions 9.1x 2.9x 30.44% ★★★★★☆
Angel Oak Mortgage REIT 12.8x 5.8x 27.38% ★★★★★☆
Appian 2303.6x 2.7x 21.52% ★★★★★☆
AVITA Medical NA 1.9x 46.72% ★★★★★☆
First Bancorp 8.9x 3.4x 31.18% ★★★★☆☆
Union Bankshares 9.3x 1.9x 20.63% ★★★★☆☆
Similarweb NA 1.3x 34.88% ★★★★☆☆
Ferroglobe NA 0.6x 19.89% ★★★★☆☆
Metropolitan Bank Holding 12.7x 3.6x 40.94% ★★★☆☆☆
German American Bancorp 12.0x 4.4x 44.93% ★★★☆☆☆

Here's a peek at a few of the choices from the screener.

Nutex Health (NUTX)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Nutex Health operates in the healthcare sector with divisions focusing on hospitals, real estate, and population health management, and has a market capitalization of approximately $1.21 billion.

Operations: The company generates revenue primarily from its Hospital Division, with additional contributions from the Population Health Management and Real Estate Divisions. Over recent periods, the gross profit margin has shown variability, reaching as high as 67.09% in September 2021 before experiencing declines to 0.02% by June 2023 and then recovering to 57.11% by September 2025. Operating expenses include significant allocations towards general and administrative costs, with non-operating expenses also impacting financial outcomes significantly at times.

PE: 9.1x

Nutex Health, a smaller player in the healthcare sector, has shown promising financial growth with Q1 2026 revenue reaching US$216.49 million, up from US$211.79 million the previous year. Net income nearly doubled to US$46.81 million, reflecting strong earnings potential despite past shareholder dilution and volatile share prices. Insider confidence is evident with recent purchases over the last few months, signaling potential value recognition by those closest to the company’s operations.

NUTX Ownership Breakdown as at Jun 2026
NUTX Ownership Breakdown as at Jun 2026

Distribution Solutions Group (DSGR)

Simply Wall St Value Rating: ★★★★★☆

Overview: Distribution Solutions Group operates as a diversified industrial distribution company providing a range of products and services across various sectors, with a market cap of $1.03 billion.

Operations: Distribution Solutions Group generates revenue primarily through its segments: Lawson, Testequity, Gexpro Services, and the Canada Branch Division. The company's gross profit margin has shown fluctuations over recent periods, reaching 34.18% at the end of 2024 and slightly decreasing to 33.10% by March 2026. Operating expenses are a significant component of costs, with general and administrative expenses consistently representing a large portion of these costs across multiple periods.

PE: 230.1x

Distribution Solutions Group, a smaller U.S. company, shows potential for growth despite some financial challenges. Their recent earnings report highlighted sales of US$496 million in Q1 2026, up from US$478 million the previous year, though net income fell to US$0.382 million from US$3.26 million. Insider confidence is evident with share purchases completed by December 2025 worth US$34.61 million since April 2019, signaling belief in future prospects despite volatile share prices and higher-risk funding sources.

DSGR Share price vs Value as at Jun 2026
DSGR Share price vs Value as at Jun 2026

Trinity Capital (TRIN)

Simply Wall St Value Rating: ★★★★☆☆

Overview: Trinity Capital is a financial services company specializing in venture capital investments, with a market capitalization of approximately $0.78 billion.

Operations: The company generates revenue primarily from its venture capital segment, with the latest reported figure being $300.16 million. Operating expenses have shown an upward trend, reaching $75.84 million in the most recent period. Notably, the gross profit margin has consistently remained at 100%.

PE: 11.2x

Trinity Capital, a smaller player in the U.S. market, recently completed a $297.54 million fixed-income offering and announced a $300 million follow-on equity offering in May 2026, indicating active capital management. Their first-quarter revenue surged to $90.13 million from last year's $65.39 million, though earnings per share dipped slightly to $0.36 from $0.43. Insider confidence is evident with recent purchases, reflecting potential optimism about future growth despite past shareholder dilution challenges and reliance on external borrowing for funding needs.

TRIN Share price vs Value as at Jun 2026
TRIN Share price vs Value as at Jun 2026

Taking Advantage

  • Click here to access our complete index of 73 Undervalued US Small Caps With Insider Buying.
  • Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
  • Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Searching for a Fresh Perspective?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.